Page 1 of Clinical Trials for Drug peginterferon, 617 Total Matches

Show/Hide Clinical Trials Which are Not Seeking New Volunteers

1
Recruiting
Peginterferon and Ribavirin, With or Without Telaprevir, for Genotype 1 Hepatitis C and IL28B CC Polymorphism
Last Updated: January 23, 2012
Condition(s): Hepatitis C
2
Completed
Different PEG-interferon and Ribavirin Schedules for Chronic Hepatitis C in the Real Clinical Practice.
Last Updated: September 3, 2010
Condition(s): Hepatitis C Virus; Chronic Liver Disease; Viral Hepatitis; Therapeutic Uses; Antiviral Agents
3
Recruiting
A Study to Treat Subjects With Telaprevir, Ribavirin, and Peginterferon Who Are Coinfected With HIV and Hepatitis C Virus (HCV)
Last Updated: May 18, 2012
Condition(s): Hepatitis C
4
Recruiting
Telaprevir in Combination With Peginterferon and Ribavirin in Treatment-experienced Black/African American Subjects.
Last Updated: May 18, 2012
Condition(s): Hepatitis C
5
Recruiting
An Open Label Study of the Effect of Telaprevir in Combination With Ribavirin and Peginterferon on HCV Infection in Stable Liver Transplant Patients
Last Updated: May 18, 2012
Condition(s): Hepatitis C
6
Recruiting
A Study to Compare the Efficacy and Safety of Quadruple Therapy (VX-222, Telaprevir,Peginterferon-Alfa-2a, Ribavirin) to Standard of Care in Subjects With Chronic Hepatitis C With Compensated Cirrhosis
Last Updated: May 21, 2012
Condition(s): Chronic Hepatitis C Virus
7
Terminated
Tolerability of Peginterferon Plus Ribavirin for Chronic Hepatitis C and HIV for Patients Receiving Antiretroviral Medication vs Not Receiving Antiretroviral Medication
Last Updated: April 19, 2007
Condition(s): Chronic Hepatitis C; HIV Infections
8
Completed
Phase 2 Study of VX-950, Pegasys®, and Copegus® in Hepatitis C
Last Updated: June 22, 2011
Condition(s): Chronic Hepatitis C
9
Recruiting
Study With PegInterferon Alfa-2a, Ribavirin and BMS-790052 With or Without BMS-650032 for Participants in Some Hepatitis C Virus (HCV) Trials
Last Updated: April 30, 2012
Condition(s): Hepatitis C Virus
10
Completed
Phase 2 Study of VX-950, Pegasys® With and Without Copegus® in Hepatitis C
Last Updated: June 22, 2011
Condition(s): Chronic Hepatitis C
11
Recruiting
Efficacy of a 12-week Regimen of Telaprevir, Peginterferon, and Ribavirin in Subjects With Interleukin-28B (IL28B) CC Genotype in Treatment-naive and Prior Relapser Subjects
Last Updated: May 18, 2012
Condition(s): Hepatitis C, Chronic
12
Completed
Interferon Gamma With Peg-Interferon Alpha 2a and Ribavirin in Non Responders Patients With Chronic Hepatitis C
Last Updated: August 29, 2007
Condition(s): Hepatitis C, Chronic
13
Completed
Evaluating the Safety of Two Medications to Treat Hepatitis C in People With Thalassemia (The HepC Study)
Last Updated: June 29, 2011
Condition(s): Hepatitis C; Thalassemia
14
Completed
Efficacy and Safety of MP-424/Peginterferon Alfa-2b/Ribavirin Combination in Treatment-Naïve Patients With Chronic Hepatitis C
Last Updated: March 6, 2011
Condition(s): Hepatitis C
15
Active, not recruiting
Study of the Anti-HCV Drug (BMS-790052) Combined With Peginterferon and Ribavirin in Patients Who Failed Prior Treatment
Last Updated: April 30, 2012
Condition(s): Hepatitis C Virus
16
Active, not recruiting
A Study of Response-Guided Duration of Combination Therapy With GS-9451, Pegasys® and Copegus® With and Without Tegobuvir (GS-9190) in Previously Untreated Subjects With Genotype 1 Chronic Hepatitis C
Last Updated: November 7, 2011
Condition(s): Hepatitis C, Chronic
17
Completed
Safety, Tolerability, PK and PD of SCH 900518 in Naive or Treatment-Experienced Subjects Infected With HCV Genotype 1 (Protocol No. P04695)(COMPLETED)
Last Updated: March 3, 2010
Condition(s): Hepatitis C, Chronic
18
Completed
Efficacy and Safety of MP-424, Peginterferon Alfa-2b, and Ribavirin in Patients With Chronic Hepatitis C Who Relapsed After Previous Interferon Based Therapy
Last Updated: March 6, 2011
Condition(s): Chronic Hepatitis C
19
Completed
Efficacy and Safety of MP-424, Peginterferon Alfa-2b and Ribavirin in Chronic Hepatitis C Who Have Not Achieved an Undetectable HCV RNA Level With Previous Interferon Based Therapy
Last Updated: March 6, 2011
Condition(s): Hepatitis C
20
Completed
Safety and Efficacy of Telaprevir in Combination With Peginterferon Alfa-2a and Ribavirin in Subjects Co-Infected With Hepatitis C Virus (HCV) and HIV
Last Updated: March 22, 2012
Condition(s): Hepatitis C; HIV Infections

Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.

The URL of this page is: http://clinicaltrialsfeeds.org/clinical-trials/results/?term=Drug+peginterferon

Page 1 of Clinical Trials for Drug peginterferon, 617 Total Matches

Get the Latest Results via Email or RSS

Subscribe via Web Newsreaders

Browse

Clinical Trials Background

About